Ke Hong

InstitutionJinyintan Hospital
AddressWuhan
Hubei
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in August 2020 and February 2021 and March 2021
    All Publications
    Bar chart showing 17 publications over 7 distinct years, with a maximum of 7 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yang J, Zhong M, Zhang E, Hong K, Yang Q, Zhou D, Xia J, Chen YQ, Sun M, Zhao B, Xiang J, Liu Y, Han Y, Xu M, Zhou X, Huang C, Shang Y, Yan H. Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19. J Mol Cell Biol. 2021 07 06; 13(3):197-209. PMID: 33751111.
      Citations:    Fields:    Translation:HumansCells
    2. Wei F, Kong D, Li T, Li A, Tan Y, Fang J, Zhuang X, Lai C, Xu W, Dong H, Ma C, Hong K, Cui Y, Tang S, Yu F, Zheng C. Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19. Clinics (Sao Paulo). 2021; 76:e2604. PMID: 34008772.
      Citations: 1     Fields:    Translation:HumansCells
    3. Cao W, Liu X, Hong K, Ma Z, Zhang Y, Lin L, Han Y, Xiong Y, Liu Z, Ruan L, Li T. Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front Immunol. 2021; 12:671443. PMID: 33831136.
      Citations: 1     Fields:    
    4. Yang J, Zhong M, Hong K, Yang Q, Zhang E, Zhou D, Xia J, Chen YQ, Sun M, Zhao B, Xiang J, Liu Y, Han Y, Xu M, Zhou X, Huang C, Shang Y, Yan H. Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study. Clin Transl Immunology. 2021; 10(3):e1259. PMID: 33728049.
      Citations: 1     
    5. Cao W, Liu X, Hong K, Ma Z, Zhang Y, Lin L, Han Y, Xiong Y, Liu Z, Ruan L, Li T. High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front Immunol. 2021; 12:627844. PMID: 33679771.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    6. Zhao B, Zhong M, Yang Q, Hong K, Xia J, Li X, Liu Y, Chen YQ, Yang J, Huang C, Yan H. Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study. Virol Sin. 2021 Oct; 36(5):859-868. PMID: 33560482.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    7. Wang Y, Lu C, Li H, Qi W, Ruan L, Bian Y, Shi H, Song H, Tu S, Zhang Y, Bai T, Cao R, Hong K, Li H, Liu L, Lu S, Rong N, Liu Y, Fang J, Shi J, Yang W, Zhao B, Yang Y, Zhao Y, Li S, Fan T, Rong P, Huang L. Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China. J Ethnopharmacol. 2021 Sep 15; 277:113888. PMID: 33529638.
      Citations: 8     Fields:    Translation:Humans
    8. Hong K, Cao W, Liu Z, Lin L, Zhou X, Zeng Y, Wei Y, Chen L, Liu X, Han Y, Ruan L, Li T. Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness. Emerg Microbes Infect. 2020 Dec; 9(1):2315-2321. PMID: 32981485.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    9. Wu Y, Hong K, Ruan L, Yang X, Zhang J, Xu J, Pan S, Ren L, Chen L, Huang C, Shang Y. Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study. Virol Sin. 2020 Dec; 35(6):768-775. PMID: 32865701.
      Citations: 4     Fields:    Translation:Humans
    10. Yang J, Zhang E, Zhong M, Yang Q, Hong K, Shu T, Zhou D, Xiang J, Xia J, Zhou X, Zhang D, Huang C, Shang Y, Yan H. Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection. Virol Sin. 2020 12; 35(6):838-841. PMID: 32822061.
      Citations: 3     Fields:    Translation:HumansCells
    11. Cao W, Liu X, Bai T, Fan H, Hong K, Song H, Han Y, Lin L, Ruan L, Li T. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019. Open Forum Infect Dis. 2020 Mar; 7(3):ofaa102. PMID: 32258207.
      Citations: 152     
    Hong's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (78)
    Explore
    _
    Co-Authors (106)
    Explore
    _
    Similar People (60)
    Explore
    _